Xanomeline (oxalate)
Xanomeline oxalate (LY246708 oxalate) is a potent and selective muscarinic receptor agonist (SMRA) and stimulates phosphoinositide hydrolysis in vivo. Xanomeline oxalate can be used for the research of Alzheimer’s disease[1].
Product Specifications
CAS Number
[141064-23-5]
Product Name Alternative
LY246708 (oxalate)
UNSPSC
12352005
Hazard Statement
H301, H312, H330, H410
Target
MAChR
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/Xanomeline-oxalate.html
Purity
99.93
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
CN1CCC=C(C2=NSN=C2OCCCCCC)C1.O=C(O)C(O)=O
Molecular Formula
C16H25N3O5S
Molecular Weight
371.45
Precautions
H301, H312, H330, H410
References & Citations
[1]F P Bymaster, et al. Xanomeline Compared to Other Muscarinic Agents on Stimulation of Phosphoinositide Hydrolysis in Vivo and Other Cholinomimetic Effects. Brain Res. 1998 Jun 8; 795 (1-2) :179-90.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
133692-ML405 100 µL
SOCS6 (Suppressor of Cytokine Signaling 6, SOCS-6, Cytokine-inducible SH2 Protein 4, CIS4, CIS-4, Suppressor of Cytokine Signaling 4, SOCS4, SOCS-4) (MaxLight 405) discontinued
Ask
View Details MBS4380629-01 0.02 mg (With BSA & Azide at 0.2mg/mL)
MMP3 (Marker of Metastasis and Rheumatoid Arthritis)
Ask
View Details MBS4380629-02 0.1 mg (With BSA & Azide at 0.2mg/mL)
MMP3 (Marker of Metastasis and Rheumatoid Arthritis)
Ask
View Details